c-JUN prevents methylation of p16INK4a (and Cdk6): the villain turned bodyguard

被引:0
|
作者
Kollmann, Karoline [1 ]
Heller, Gerwin [2 ]
Sexl, Veronika [1 ]
机构
[1] Univ Vet Med, Inst Pharmacol & Toxicol, Vienna, Austria
[2] Med Univ Vienna, Div Clin Oncol, Dept Med 1, Vienna, Austria
基金
奥地利科学基金会;
关键词
AP-1; CDK6; p16; leukemia; CELL-CYCLE PROGRESSION; MEDIATED DOWN-REGULATION; CHRONIC MYELOID-LEUKEMIA; DEPENDENT KINASE-6; GENE-EXPRESSION; TUMOR PROMOTION; FOS-JUN; AP-1; PROLIFERATION; TRANSFORMATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A novel way by which the AP-1 factor c-JUN interferes with tumorigenesis has recently been elucidated [1]. In a model of murine leukemia, c-JUN prevents the epigenetic silencing of the cell cycle kinase CDK6. In the absence of c-JUN, CDK6 is down-regulated and the 5'region of the gene is methylated. Down-regulation of CDK6 results in significantly delayed leukemia formation. Here we show that c-JUN is also involved in protecting the promoter region of the tumor suppressor p16(INK4a), which is consistently methylated over time in c-JUN deficient cells. In cells expressing c-JUN, p16(INK4a) promoter methylation is a less frequent event. Our study unravels a novel mechanism by which the AP-1 factor c-JUN acts as a "bodyguard", and preventing methylation of a distinct set of genes after oncogenic transformation.
引用
收藏
页码:422 / 427
页数:6
相关论文
共 50 条
  • [1] CDK6 and p16INK4A in lymphoid malignancies
    Kollmann, Karoline
    Sexl, Veronika
    ONCOTARGET, 2013, 4 (11) : 1858 - 1859
  • [2] CDK6 Degradation Is Counteracted by p16INK4A and p18INK4C in AML
    Schmalzbauer, Belinda S.
    Thondanpallil, Teresemary
    Heller, Gerwin
    Schirripa, Alessia
    Sperl, Clio-Melina
    Mayer, Isabella M.
    Knab, Vanessa M.
    Nebenfuehr, Sofie
    Zojer, Markus
    Mueller, Andre C.
    Fontaine, Frederic
    Klampfl, Thorsten
    Sexl, Veronika
    Kollmann, Karoline
    CANCERS, 2022, 14 (06)
  • [3] Structural analysis of the inhibition of Cdk4 and Cdk6 by p16INK4a through molecular dynamics simulations
    Villacañas, O
    Pérez, JJ
    Rubio-Martínez, J
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2002, 20 (03): : 347 - 358
  • [4] A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6
    Jones, Rebecca
    Ruas, Margarida
    Gregory, Fiona
    Moulin, Stephanie
    Delia, Domenico
    Manoukian, Siranoush
    Rowe, Janice
    Brookes, Sharon
    Peters, Gordon
    CANCER RESEARCH, 2007, 67 (19) : 9134 - 9141
  • [5] Functional availability of γ-herpesvirus K-cyclin is regulated by cellular CDK6 and p16INK4a
    Yoshioka, Hidenori
    Noguchi, Kohji
    Katayama, Kazuhiro
    Mitsuhashi, Junko
    Yamagoe, Satoshi
    Fujimuro, Masahiro
    Sugimoto, Yoshikazu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (04) : 1000 - 1005
  • [6] Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a
    Alicia A. Russo
    Lily Tong
    Jie-Oh Lee
    Philip D. Jeffrey
    Nikola P. Pavletich
    Nature, 1998, 395 : 237 - 243
  • [7] Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a
    Russo, AA
    Tong, L
    Lee, JO
    Jeffrey, PD
    Pavletich, NP
    NATURE, 1998, 395 (6699) : 237 - 243
  • [8] The tumor suppressor p16INK4a prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity
    Choi, BY
    Choi, HS
    Ko, K
    Cho, YY
    Zhu, F
    Kang, BS
    Ermakova, SP
    Ma, WY
    Bode, AM
    Dong, ZG
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2005, 12 (08) : 699 - 707
  • [9] The tumor suppressor p16INK4a prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity
    Bu Young Choi
    Hong Seok Choi
    Kwangseok Ko
    Yong-Yeon Cho
    Feng Zhu
    Bong Seok Kang
    Svetlana P Ermakova
    Wei-Ya Ma
    Ann M Bode
    Zigang Dong
    Nature Structural & Molecular Biology, 2005, 12 : 699 - 707
  • [10] Cdk6–cyclin D3 activity in murine ES cells is resistant to inhibition by p16INK4a
    Renate Faast
    Josephine White
    Peter Cartwright
    Lesley Crocker
    Boris Sarcevic
    Stephen Dalton
    Oncogene, 2004, 23 : 491 - 502